Published in Hepatitis Weekly, September 6th, 2004
Total reported company revenue for the 14-week quarter ending July 2, 2004 was a record $157.7 million, up $42.3 million or 37% from $115.4 million in the prior year's 13-week fourth quarter.
Operating income as reported was a record $3.2 million for the quarter, up 48% from last year's fourth quarter. Net income as reported was a record $2.0 million, or $0.16 per share, compared to $1.4 million or $0.11 per share in last year's fourth quarter.
Henry F. Blissenbach, Chronimed's chairman and CEO, commented, "We are quite...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.